Hepatitis Monthly

Published by: Kowsar

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies

Mohammad Saeid Rezaee Zavareh 1 , 2 and Seyed Moayed Alavian 2 , *
Authors Information
1 Students’ Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: November 01, 2015, 15 (11); e33462
  • Published Online: November 28, 2015
  • Article Type: Editorial
  • Received: September 28, 2015
  • Accepted: October 4, 2015
  • DOI: 10.5812/hepatmon.33462

To Cite: Rezaee Zavareh M S, Alavian S M. Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies, Hepat Mon. 2015 ; 15(11):e33462. doi: 10.5812/hepatmon.33462.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Hepatitis C Virus Infection, a Global Concern
2. Occult Hepatitis C Virus Infection and Its Clinical Significance
3. New Treatment Regimens and Occult Hepatitis C Infection
4. Conclusions
  • 1. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012; 18(23): 2887-94[DOI][PubMed]
  • 2. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006; 13(1): 34-41[DOI][PubMed]
  • 3. Ermis F, Senocak Tasci E. New treatment strategies for hepatitis C infection. World J Hepatol. 2015; 7(17): 2100-9[DOI][PubMed]
  • 4. Ozaras R, Tahan V. Acute hepatitis C: prevention and treatment. Expert Rev Anti Infect Ther. 2009; 7(3): 351-61[DOI][PubMed]
  • 5. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011; 83(6): 989-95[DOI][PubMed]
  • 6. Rezaee Zavareh MS, Alavian SM, Karimisari H, Shafiei M, Saiedi Hosseini SY. Occult hepatitis C virus infection in patients with autoimmune hepatitis. Hepat Mon. 2014; 14(8)[DOI][PubMed]
  • 7. Rezaee-Zavareh MS, Ramezani-Binabaj M, Moayed Alavian S. Screening for occult hepatitis C virus infection: Does it need special attention? Hepatology. 2015; 62(1): 321-2[DOI][PubMed]
  • 8. Gatserelia L, Sharvadze L, Karchava M, Dolmazashvili E, Tsertsvadze T. Occurrence of occult HCV infection among Hiv infected patients in Georgia. Georgian Med News. 2014; (226): 37-41[PubMed]
  • 9. Youssef SS, Nasr AS, El Zanaty T, El Rawi RS, Mattar MM. Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders. Hepat Res Treat. 2012; 2012: 429784[DOI][PubMed]
  • 10. Alavian SM. Sofosbuvir has come out of the magic box. Hepat Mon. 2013; 13(12)[DOI][PubMed]
  • 11. Pol S, Sulkowski MS, Hassanein T, Gane EJ, Liu L, Mo H, et al. Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed. Hepatology. 2015; 62(1): 129-34[DOI][PubMed]
  • 12. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014; 370(20): 1889-98[DOI][PubMed]
  • 13. Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014; 370(16): 1483-93[DOI][PubMed]
  • 14. Rezaee-Zavareh MS, Einollahi B. Treatment of occult hepatitis C virus infection: does it need special attention? Hepat Mon. 2014; 14(7)[DOI][PubMed]
  • 15. Casato M, Lilli D, Donato G, Granata M, Conti V, Del Giudice G, et al. Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat. 2003; 10(6): 455-9[PubMed]
  • 16. Pardo M, Lopez-Alcorocho JM, Castillo I, Rodriguez-Inigo E, Perez-Mota A, Carreno V. Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther. 2006; 23(8): 1153-9[DOI][PubMed]
  • 17. Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009; 49(2): 665-75[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments